Drreddys Laboratories | RDY - Cost Of Sales


Drreddys Laboratories reported INR40.46B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
ANI Pharmaceuticals USD 116.02M 18.12M Sep/2025
Aurora Cannabis CAD 58.08M 11.99M Sep/2025
Bayer EUR 4.31B 57M Sep/2025
Canopy Growth CAD 44.78M 9.32M Sep/2025
Cipla INR 29.1B 1.16B Dec/2025
Corcept Therapeutics USD 4.6M 1.16M Sep/2025
Drreddys Laboratories INR 40.46B 3.64B Dec/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
Hikma Pharmaceutical USD 466.5M 428.5M Jun/2025
Lonza CHF 2.28B 189M Jun/2025
Novartis USD 3.54B 217M Sep/2025
Pacira USD 48.6M 6.59M Sep/2025
Prestige Brands USD 131.22M 3.52M Dec/2025
Richter Gedeon HUF 71.32B 2.26B Sep/2025
Sun Pharmaceuticals INR 36.77B 348M Dec/2025
Supernus Pharmaceuticals USD 43.29M 5.64M Sep/2025
Teva Pharmaceutical Industries USD 2.06B 120M Dec/2025